Janson ET - Search Results

1

Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.

Janson ET, Sorbye H, Welin S, Federspiel B, Grønbæk H, Hellman P, Ladekarl M, Langer SW, Mortensen J, Schalin-Jäntti C, Sundin A, Sundlöv A, Thiis-Evensen E, Knigge U. Janson ET, et al. Acta Oncol. 2014 Oct;53(10):1284-97. doi: 10.3109/0284186X.2014.941999. Epub 2014 Aug 20. Acta Oncol. 2014. PMID: 25140861 Review.

2

Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon.

Janson ET, Oberg K. Janson ET, et al. Acta Oncol. 1993;32(2):225-9. doi: 10.3109/02841869309083916. Acta Oncol. 1993. PMID: 7686765 Clinical Trial.

3

The clinical use of interferons in the management of neuroendocrine gastroenteropancreatic tumors.

Oberg K, Eriksson B, Janson ET. Oberg K, et al. Among authors: janson et. Ann N Y Acad Sci. 1994 Sep 15;733:471-8. doi: 10.1111/j.1749-6632.1994.tb17297.x. Ann N Y Acad Sci. 1994. PMID: 7978897 Review. No abstract available.

4

Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide.

Westlin JE, Janson ET, Arnberg H, Ahlström H, Oberg K, Nilsson S. Westlin JE, et al. Among authors: janson et. Acta Oncol. 1993;32(7-8):783-6. doi: 10.3109/02841869309096136. Acta Oncol. 1993. PMID: 8305227

5

Combined alpha- and gamma-interferon therapy for malignant midgut carcinoid tumors. A phase I-II trial.

Janson ET, Kauppinen HL, Oberg K. Janson ET, et al. Acta Oncol. 1993;32(2):231-3. doi: 10.3109/02841869309083917. Acta Oncol. 1993. PMID: 8323762 Clinical Trial.

6

Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs.

Imam H, Eriksson B, Lukinius A, Janson ET, Lindgren PG, Wilander E, Oberg K. Imam H, et al. Among authors: janson et. Acta Oncol. 1997;36(6):607-14. doi: 10.3109/02841869709001323. Acta Oncol. 1997. PMID: 9408151

7

Tumour markers in neuroendocrine tumours.

Oberg K, Janson ET, Eriksson B. Oberg K, et al. Among authors: janson et. Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S160-2. Ital J Gastroenterol Hepatol. 1999. PMID: 10604122 Review.

8

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors.

Fjällskog ML, Granberg DP, Welin SL, Eriksson C, Oberg KE, Janson ET, Eriksson BK. Fjällskog ML, et al. Among authors: janson et. Cancer. 2001 Sep 1;92(5):1101-7. doi: 10.1002/1097-0142(20010901)92:5<1101::aid-cncr1426>3.0.co;2-v. Cancer. 2001. PMID: 11571721 Clinical Trial.

9

Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs.

Fjällskog ML, Sundin A, Westlin JE, Oberg K, Janson ET, Eriksson B. Fjällskog ML, et al. Among authors: janson et. Med Oncol. 2002;19(1):35-42. doi: 10.1385/MO:19:1:35. Med Oncol. 2002. PMID: 12025889

10

Malignant neuroendocrine tumors.

Janson ET, Oberg K. Janson ET, et al. Cancer Chemother Biol Response Modif. 2002;20:463-70. Cancer Chemother Biol Response Modif. 2002. PMID: 12703220 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page